Bronway Tabaco Competitors

We are BAT, a leading global consumer goods company driven by a clear purpose: to create A Better Tomorrow™ by Building a Smokeless World. Founded in 1902, we’ve grown into a truly international business, operating across six continents with a presence in over 180 markets. Our strategic ambition is to become a predominantly smokeless business by 2035**, helping adult smokers transition to scientifically substantiated, reduced-risk*† alternatives. With a powerful portfolio of global brands, a future-focused strategy, and around 50,000 talented people worldwide, we are committed to accelerating Tobacco Harm Reduction and making cigarettes a thing of the past. As a leading FTSE company, our operations span three key regions: 🌍 United States of America 🌍 Americas & Europe (AME) 🌍 Asia Pacific, Middle East & Africa (APMEA) Together, we are building A Better Tomorrow™. * Based on the weight of evidence and assuming a complete switch from cigarette smoking. These products are not risk free and are addictive. **Please refer to the cautionary statement contained in the Annual Report and Form 20-F 2024 on p.447 for additional information regarding BAT’s future performance: https://www.bat.com/ar/2024/index.html † Our Vapour product Vuse (including Alto, Solo, Ciro and Vibe), and certain products, including Velo, Grizzly, Kodiak, and Camel Snus, which are sold in the U.S., are subject to FDA regulation and no reduced-risk claims will be made as to these products without agency clearance.

We have a leading portfolio of tobacco products for U.S. tobacco consumers age 21+. Our Vision is to responsibly lead the transition of adult smokers to a smoke-free future (Vision). We areMoving Beyond Smoking®, leading the way in moving adult smokers away from cigarettes by taking action to transition millions to potentially less harmful choices - believing it is a substantial opportunity for adult tobacco consumers, our businesses and society. Our wholly owned subsidiaries include leading manufacturers of both combustible and smoke-free products. In combustibles, we own Philip Morris USA Inc. (PM USA), the most profitable U.S. cigarette manufacturer, and John Middleton Co. (Middleton), a leading U.S. cigar manufacturer. Our smoke-free portfolio includes ownership of U.S. Smokeless Tobacco Company LLC (USSTC), the leading global moist smokeless tobacco (MST) manufacturer, Helix Innovations LLC (Helix), a leading manufacturer of oral nicotine pouches, and NJOY, LLC (NJOY), an e-vapor manufacturer with a commercialized product portfolio fully covered by marketing granted orders from the U.S. Food and Drug Administration (FDA). Additionally, we have a majority-owned joint venture, Horizon Innovations LLC (Horizon), for the U.S. marketing and commercialization of heated tobacco stick products. Our equity investments include Anheuser-Busch InBev SA/NV (ABI), the world’s largest brewer, and Cronos Group Inc. (Cronos), a leading Canadian cannabinoid company. The brand portfolios of our operating companies includeMarlboro®,Black & Mild®,Copenhagen®,Skoal®,on!® andNJOY®. Trademarks related to Altria referenced in this release are the property of Altria or our subsidiaries or are used with permission. Learn more about Altria atwww.altria.com.

Philip Morris International (PMI) is a leading international consumer goods company working to deliver a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. Since 2008, PMI has invested more than USD 15 billion to develop, scientifically substantiate and commercialize innovative smoke-free products for adults who would otherwise continue to smoke, with the goal of completely ending the sale of cigarettes. In November 2022, PMI acquired Swedish Match – a leader in oral nicotine delivery – creating a global smoke-free champion led by the companies’ IQOS and ZYN brands. As of Q2 2025, PMI's smoke-free products were available for sale in 97 markets and smoke-free products accounted for approximately 41% of net revenues. With a strong foundation and significant expertise in life sciences, PMI announced in February 2021 its ambition to expand into wellness and healthcare areas and aims to enhance life through the delivery of seamless health experiences. For more information, please visit www.pmi.com and www.pmiscience.com. Our priority is to attract, support and keep with us diverse and unique individuals. Our global workforce of more than 69,000 people is one of our greatest strengths and the key to our success as a company. Our employees speak more than 80 languages and come from all corners of the world. PMI has also been certified as a “Global Top Employer” for the seventh consecutive year, in recognition of the high standards of excellence in our working environment and the exceptional development opportunities we offer. If you come into our offices or meet our people, you will quickly realize that at PMI everyone has the opportunity to make a difference and build phenomenal careers.